Masimo's CEO and CFO reported on August 13, 2025, detailing margin expansion and updated EPS guidance.
1 report, 1 independent
Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Masimo's CEO and CFO reported on August 13, 2025, detailing margin expansion and updated EPS guidance.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Masimo
American healthcare company
Nothing else this week.
Coverage
Newest first; wire copies grouped- StockStoryMASI Q2 Deep Dive: Margin Expansion Amid Tariff Pressures and Strategic Leadership Changes Medical tech company Masimo (NASDAQ:MASI) reported revenue ahead of Wall Street’s expectations in Q2 CY2025,